Download PDF
Klin Monbl Augenheilkd 2005; 222(5): 390-395
DOI: 10.1055/s-2005-858231
Statement

© Georg Thieme Verlag KG Stuttgart · New York

Empfehlung für die Durchführung von intravitrealen Injektionen

Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschland (BVA)Recommendation for the Procedure of Intravitreal Injections of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)G. B. Jaissle1 , P. Szurman1 , K. U. Bartz-Schmidt1
  • 1Universitäts-Augenklinik Tübingen, Abt. I
Further Information

Publication History

Publication Date:
23 May 2005 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die intravitreale Injektion als minimalinvasiver Eingriff stellt bei zahlreichen vitreoretinalen Krankheitsbildern eine wertvolle Behandlungsform dar. Nicht standardisiertes Durchführen der Injektion kann jedoch zu schwerwiegenden Komplikationen führen. Die hier diskutierten Empfehlungen zur Durchführung der intravitrealen Injektion sollen daher zur Minimierung des Komplikationsrisikos beitragen. Bedeutsam ist insbesondere eine intensive präoperative Antisepsis mit Povidon Jod, ein steriles Arbeiten mit sterilem Lidspekulum, Abdecktuch und Handschuhen, Anwenden einer adäquaten Injektionstechnik sowie der Ausschluss einer postoperativen retinalen Perfusionsstörung.

Abstract

The intravitreal injection as a minimally invasive intervention has proved to be an effective therapy in the management of numerous vitreoretinal diseases. However, non-standardized performance of the procedure might cause severe complications. The recommendations for intravitreal injections discussed here are intended to contribute to a minimization of the risk for complications. Of particular importance are a meticulous preoperative antisepsis with povidon iodine, a sterile environment using a sterile lid speculum, drape and gloves, the use of an adequate injection technique and the exclusion of postoperative retinal non-perfusion.

Schlüsselwörter

Intravitreale Injektion - Injektionsstandard - Durchführung - Komplikationen - Risikofaktoren - Triamcinolon - Macugen

Key words

Intravitreal Injection - standards for injection - complications - risk factors - triamcinolone - Macugen

Literatur

  • 1 Abe T, Nakajima A, Nakamura H. et al . Intraocular pressure during pneumatic retinopexy.  Ophthalmic Surg Lasers. 1998;  29 391-193
    PubMedGoogle Scholar
  • 2 Aiello L P, Brucker A J, Chang S. et al . Evolving guidelines for intravitreous injections.  Retina. 2004;  24 S3-S19
    CrossrefPubMedGoogle Scholar
  • 3 Apt L, Isenberg S, Yoshimori R. et al . Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva.  Arch Ophthalmol. 1984;  102 728-729
    PubMedGoogle Scholar
  • 4 Bakri S J, Shah A, Falk N S. et al . Intravitreal preservative-free triamcinolone acetonide for the treatment of macular edema.  Epup Eye Aug. 2004;  27
    PubMedGoogle Scholar
  • 5 Buzard K, Liapis S. Prevention of endophthalmitis.  J Cataract Refract Surg. 2004;  30 1953-1959
    CrossrefPubMedGoogle Scholar
  • 6 Ciardella A P, Klancnik J, Schiff W. et al . Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.  Br J Ophthalmol. 2004;  88 1131-1136
    CrossrefPubMedGoogle Scholar
  • 7 Ciulla T A, Walker J D, Fong D S. et al . Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.  Curr Opin Ophthalmol. 2004;  15 211-220
    PubMedGoogle Scholar
  • 8 Coden D J, Freeman W R, Weinreb R N. Intraocular pressure response after pneumatic retinopexie.  Ophthalmic surgery. 1988;  19 667-669
    PubMedGoogle Scholar
  • 9 Danis R P, Ciulla T A, Pratt L M. et al . Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.  Retina. 2000;  20 244-250
    CrossrefPubMedGoogle Scholar
  • 10 De Kaspar H M, Chang R, Egbert P. Greater elimination of conjunctiva bacteria after preoperative irrigation with 10 cc of 5 % povidone-iodine. Presented at: Annual Meeting of the American Academy of Ophthalmology. Anaheim, Florida; November 15 - 18, 2003
    Google Scholar
  • 11 De Kaspar H M, Shriver E M, Nguyen E V. et al . Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery.  Graefe’s Arch Clin Exp Ophthalmol. 2003;  241 730-733
    PubMedGoogle Scholar
  • 12 Eckardt C. Staphylococcus epidermidis endophthalmitis after pneumatic retinopexy.  Am J Ophthalmol. 1987;  103 720-721
    PubMedGoogle Scholar
  • 13 Ferguson A W, Scott J A, McGavigan J. et al . Comparison of 5 % Povidone-Iodine solution against 1 % Povidone-Iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study.  Br J Ophthalmol. 2003;  87 163-167
    CrossrefPubMedGoogle Scholar
  • 14 Flynn H W, Scott I U. Introduction. Intravitreal injections: The route of retinal pharmacotherapies.  Retina. 2004;  24 S1
    PubMedGoogle Scholar
  • 15 Gillies M C, Simpson J M, Luo W. et al . A randomized clinical trail of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration. One-year results.  Arch Ophthalmol. 2003;  121 667-673
    CrossrefPubMedGoogle Scholar
  • 16 Goldstein M H, Kowalski R P, Gordon Y J. Emerging fluoroquinolone resistance in bacterial keratitis. A 5-year review.  Ophthalmology. 1999;  106 1313-1318, discussion 1318
    PubMedGoogle Scholar
  • 17 Gupta M S, McKee H DR, Stewart O G. Perioperative prophylaxis for cataract surgery: Survey of ophthalmologists in the north of England.  J Cataract Refract Surg. 2004;  30 2021-2022
    PubMedGoogle Scholar
  • 18 Handwerger B A, Blodi B A, Chandra S R. et al . Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.  Arch Ophthalmol. 2001;  119 28-32
    PubMedGoogle Scholar
  • 19 Hanscom T A. Postoperative endophthalmitis.  Clin Infect Dis. 2004;  38 542-546
    CrossrefPubMedGoogle Scholar
  • 20 Hilton G F, Grizzard W S. A two-step outpatient operation without conjunctival incision.  Ophthalmology. 1986;  93 626-641
    PubMedGoogle Scholar
  • 21 Hilton G F, Kelly N E, Salzano T C. et al . Pneumatic retinopexie. A collaborative report of the first 100 cases.  Ophthalmology. 1987;  94 307-314
    PubMedGoogle Scholar
  • 22 Hilton G F, Tornambe P E. The retinal detachment study group. Pneumatic retinopexy. An analysis of intraoperative and postoperative complications.  Retina. 1991;  11 285-294
    PubMedGoogle Scholar
  • 23 Isenberg S J, Apt L, Yoshimori R. et al . Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of Povidone-Iodine on the conjunctiva with a prophylactic antibiotic.  Arch Ophthalmol. 1985;  103 1340-1342
    CrossrefPubMedGoogle Scholar
  • 24 Jager R D, Aiello L P, Patel S C. et al . Risks of intravitreous injection: a comprehensive review.  Retina. 2004;  24 676-698
    CrossrefPubMedGoogle Scholar
  • 25 Jonas J B, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide.  Br J Ophthalmol. 2003;  87 24-27
    CrossrefPubMedGoogle Scholar
  • 26 Jonas J B, Kreissig I, Degenring R F. Endophthalmitis after intravitreal injection of triamcinolone acetonide.  Arch Ophthalmol. 2003;  121 1663-1664
    CrossrefPubMedGoogle Scholar
  • 27 Jonas J B, Kreissig I, Degenring R F. Retinal complications of intravitreal injections of triamcinolone acetonide.  Graefe’s Arch Clin Exp Ophthalmol. 2004;  242 184-185
    PubMedGoogle Scholar
  • 28 Keverline M R, Kowalski R P, Dhaliwal D K. In vitro comparison of Ciprofloxacin, Ofloxacin, and Povidone-Iodine for surgical propyhlaxis.  J Cataract Refract Surg. 2002;  28 915-916
    CrossrefPubMedGoogle Scholar
  • 29 Kirsch L S, Arevalo J F, De Clercq E. et al . Phase I/II study if intravitreal Cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.  Am J Ophthalmol. 1995;  119 466-476
    PubMedGoogle Scholar
  • 30 Krepler K, Kruger A, Tittl M. et al . Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.  Retina. 2000;  20 251-256
    PubMedGoogle Scholar
  • 31 Leitlinien von BVA und DOG. augeninfo.de/leit/index.htm. 
    Google Scholar
  • 32 Leong J K, Shah R, McCluskey P J. et al . Bacterial contamination of the anterior chamber during phakoemulsification cataract surgery.  J Cataract Refract Surg. 2002;  28 826-833
    CrossrefPubMedGoogle Scholar
  • 33 Magugen, FDA.com. 
    Google Scholar
  • 34 Mamalis N, Kearsley L, Brinton E. Postoperative endophthalmitis.  Curr Opin Ophthalmol. 2002;  13 14-18
    CrossrefPubMedGoogle Scholar
  • 35 Mather R, Karenchak L M, Romanowski E G. et al . Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics.  Am J Ophthalmol. 2002;  133 463-466
    CrossrefPubMedGoogle Scholar
  • 36 Moshfeghi D M, Kaiser P K, Scott I U. et al . Acute Endophthalmitis following intravitreal triamcinolone acetonide injection.  Am J Ophthalmol. 2003;  136 791-796
    CrossrefPubMedGoogle Scholar
  • 37 Nelson M L, Tennant M TS, Sivalingam A. et al . Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.  Retina. 2003;  23 686-691
    CrossrefPubMedGoogle Scholar
  • 38 Parke D W. Intravitreal triamcinolone and endophthalmitis.  Am J Ophthalmol. 2003;  136 918-919
    CrossrefPubMedGoogle Scholar
  • 39 Penfold P L, Gyory J F, Hunyor A B. et al . Exudative macular degeneration and intravitreal triamcinolone. A pilot study.  Aust N Z J Ophthalmol. 1995;  23 293-298
    PubMedGoogle Scholar
  • 40 Perry L D, Skaggs C. Preoperative topical antibiotics and lash trimming in cataract surgery.  Ophthalmic Surg. 1977;  8 44-48
    PubMedGoogle Scholar
  • 41 Roth D B, Chieh J, Spirn M J. et al . Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.  Arch Ophthalmol. 2003;  121 1279-1282
    CrossrefPubMedGoogle Scholar
  • 42 Sakamoto T, Enaida H, Kubota T. et al . Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy.  Am J Ophthalmol. 2004;  138 137-138
    CrossrefPubMedGoogle Scholar
  • 43 Schmitz S, Dick H B, Krummenauer F. et al . Endophthalmitis in cataract surgery. Results of a German survey.  Ophthalmology. 1999;  64 1084-1087
    PubMedGoogle Scholar
  • 44 Snyder-Perlmutter L, Katz H R, Melia M. Effect of topical ciprofloxacin 0.3 % and ofloxacin 0.3 % on the reduction of bacterial flora on the human conjunctiva.  J Cataract Refract Surg. 2000;  26 1620-1625
    CrossrefPubMedGoogle Scholar
  • 45 Speaker M G, Menikoff J A. Prophylaxis of endophthalmitis with topical povidone-iodine.  Ophthalmology. 1991;  98 1769-1775
    CrossrefPubMedGoogle Scholar
  • 46 Speaker M G, Milch F A, Shah M K. et al . Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis.  Ophthalmology. 1991;  98 639-649, discussion 650
    PubMedGoogle Scholar
  • 47 Starr M B, Lally J M. Antimicrobial prophylaxis for ophthalmic surgery.  Surv Ophthalmol. 1995;  39 485-501
    PubMedGoogle Scholar
  • 48 Sutter F KP, Gillies M C. Interim (3 months) analysis of the safety of intravitreal triamcinolone for diabetic macular oedema that persists after laser treatment. Results from a randomized clinical trial: TDMO.  Invest Ophthalmol Vis Sci. 2003;  44: ARVO E-Abstract 454
    PubMedGoogle Scholar
  • 49 Sutter F KP, Gillies M C. Pseudo-endophthalmitis after intravitreal injection of triamcinolone.  Br J Ophthalmol. 2003;  87 972-974
    CrossrefPubMedGoogle Scholar
  • 50 Ta C N. Minimizing the risk of endophthalmitis following intravitreous injections.  Retina. 2004;  24 699-705
    CrossrefPubMedGoogle Scholar
  • 51 Ta C N, Egbert P R, Singh K. et al . Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery.  Ophthalmology. 2002;  109 2036-2040, discussion 2040 - 2041
    CrossrefPubMedGoogle Scholar
  • 52 Tornambe P E, Hilton G F. The retinal detachment study group. Pneumatic retinopexy. A multicenter randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling.  Ophthalmology. 1988;  96 772-784
    PubMedGoogle Scholar

Dr. Gesine B. Jaissle und Karl Ulrich Bartz-Schmidt

Universitäts-Augenklinik Tübingen, Abt. I

Schleichstraße 12

72076 Tübingen

Phone: +49-70 71-2 98 47 70

Fax: +49-70 71-29 46 76

Email: g.jaissle@med.uni-tuebingen.de